| LLY |
Eli Lilly and Company |
764.08B |
18.35% |
|
|
|
|
|
806.00 |
-10.34% |
43.54% |
44.90% |
|---|
| BMY |
Bristol-Myers Squibb Company |
101.08B |
7.03% |
|
|
|
|
|
49.67 |
-1.06% |
42.70% |
60.71% |
|---|
| NVS |
Novartis AG |
220.45B |
6.59% |
|
|
|
|
|
111.24 |
-1.99% |
25.57% |
46.26% |
|---|
| AMGN |
Amgen Inc. |
152.74B |
6.15% |
|
|
|
|
|
284.10 |
-2.35% |
41.20% |
56.98% |
|---|
| AZN |
AstraZeneca PLC |
435.69B |
5.78% |
|
|
|
|
|
70.27 |
-2.12% |
34.59% |
53.90% |
|---|
| USBGFS7 |
US BANK MMDA - USBGFS 7 06/01/2031 |
|
5.21% |
|
|
|
|
|
|
|
|
|
|---|
| JNJ |
Johnson & Johnson |
372.00B |
5.17% |
|
|
|
|
|
154.37 |
-1.24% |
22.59% |
34.98% |
|---|
| PFE |
Pfizer Inc. |
135.80B |
4.83% |
|
|
|
|
|
23.95 |
-1.90% |
39.52% |
46.99% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
33.46B |
4.80% |
|
|
|
|
|
257.26 |
-2.27% |
41.52% |
36.77% |
|---|
| ALKS |
Alkermes plc |
5.00B |
4.68% |
|
|
|
|
|
30.33 |
5.42% |
55.46% |
121.60% |
|---|
| MRK |
Merck & Co., Inc. |
210.02B |
4.67% |
|
|
|
|
|
83.46 |
-2.04% |
41.05% |
63.29% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
62.34B |
3.57% |
|
|
|
|
|
582.91 |
-2.65% |
49.81% |
76.60% |
|---|
| BIIB |
Biogen Inc. |
17.84B |
3.31% |
|
|
|
|
|
121.85 |
0.64% |
46.34% |
53.16% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
5.06B |
3.08% |
|
|
|
|
|
31.84 |
3.68% |
57.02% |
61.42% |
|---|
| CRSP |
CRISPR Therapeutics AG |
3.25B |
2.88% |
|
|
|
|
|
37.69 |
-2.55% |
66.84% |
64.32% |
|---|
| GSK |
GSK plc |
78.75B |
2.68% |
|
|
|
|
|
38.87 |
-2.46% |
24.43% |
45.68% |
|---|
| BEAM |
Beam Therapeutics Inc. |
2.03B |
1.71% |
|
|
|
|
|
20.21 |
1.40% |
63.92% |
49.12% |
|---|
| BCYC |
Bicycle Therapeutics plc |
607.05M |
1.44% |
|
|
|
|
|
8.79 |
2.69% |
250.22% |
100.05% |
|---|
| REPL |
Replimune Group, Inc. |
752.82M |
1.25% |
|
|
|
|
|
9.78 |
-0.05% |
122.01% |
14.82% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
896.97M |
1.16% |
|
|
|
|
|
8.67 |
-2.31% |
84.48% |
66.92% |
|---|
| HLN |
Haleon plc |
46.59B |
0.95% |
|
|
|
|
|
10.33 |
1.77% |
54.43% |
27.25% |
|---|
| VNDA |
Vanda Pharmaceuticals Inc. |
263.14M |
0.87% |
|
|
|
|
|
4.47 |
-1.00% |
86.92% |
32.39% |
|---|
| LTRN |
Lantern Pharma Inc. |
38.72M |
0.67% |
|
|
|
|
|
3.59 |
1.99% |
118.31% |
40.07% |
|---|
| SDZNY |
Sandoz Group AG |
|
0.56% |
|
|
|
|
|
|
|
|
|
|---|
| GEHC |
GE HealthCare Technologies Inc. |
31.15B |
0.53% |
|
|
|
|
|
68.04 |
-3.26% |
48.14% |
62.18% |
|---|
| GALT |
Galectin Therapeutics Inc. |
82.07M |
0.42% |
|
|
|
|
|
1.2990 |
-5.18% |
302.34% |
11.84% |
|---|
| TSVT |
2seventy bio, Inc. |
265.18M |
0.35% |
|
|
|
|
|
4.98 |
-0.16% |
368.39% |
33.70% |
|---|
| VTRS |
Viatris Inc. |
10.17B |
0.31% |
|
|
|
|
|
8.52 |
1.19% |
30.87% |
74.08% |
|---|
| ALLO |
Allogene Therapeutics, Inc. |
359.57M |
0.29% |
|
|
|
|
|
1.6550 |
-1.49% |
677.77% |
87.88% |
|---|
| EDIT |
Editas Medicine, Inc. |
133.94M |
0.27% |
|
|
|
|
|
1.6000 |
-3.03% |
146.68% |
59.06% |
|---|
| PACB |
Pacific Biosciences of California, Inc. |
331.55M |
0.15% |
|
|
|
|
|
1.1050 |
-0.45% |
120.73% |
32.23% |
|---|
| Cash&Other |
Cash & Other |
|
0.14% |
|
|
|
|
|
|
|
|
|
|---|
| BLUE |
bluebird bio, Inc. |
40.38M |
0.10% |
|
|
|
|
|
4.13 |
1.10% |
122.15% |
11.34% |
|---|
| MURA |
Mural Oncology plc |
44.95M |
0.05% |
|
|
|
|
|
2.6092 |
-0.79% |
394.12% |
6.97% |
|---|
| SLRX |
Salarius Pharmaceuticals, Inc. |
1.43M |
0.04% |
|
|
|
|
|
0.6700 |
-5.63% |
N/A |
N/A |
|---|
| 2368714D |
Pathos AI Inc |
|
N/A |
|
|
|
|
|
|
|
|
|
|---|